コレマツ セイゴ
KOREMATSU Seigo
是松 聖悟 所属 埼玉医科大学 医学部 総合医療センター 小児科(小児科、総合周産期母子医療センター新生児科、小児救命救急センター) 職種 教授 |
|
論文種別 | 学術雑誌(原著) |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy |
掲載誌名 | 正式名:CLINICAL AND EXPERIMENTAL ALLERGY ISSNコード:09547894 |
出版社 | WILEY-BLACKWELL PUBLISHING, INC |
巻・号・頁 | 41(2),186-191頁 |
著者・共著者 | H. Miyahara,N. Okazaki,T. Nagakura,S. Korematsu,T. Izumi |
発行年月 | 2011/02 |
概要 | Background Thymus-and-activation-regulated chemokine (TARC; CCL17) is related to both allergy and pregnancy, but the relationships of maternal and umbilical cord blood CCL17 to atopic dermatitis (AD) development have not yet been examined. Objective Seventy paired full-term and normal vaginal delivery newborns and their mothers were enrolled in this study.Methods To elucidate the pathogenesis and fetomaternal inheritance of AD in infancy, CCL17, IFN-gamma-inducible protein 10 kDa (IP-10; CXCL10), soluble HLA-G (sHLA-G), IgE and eosinophil counts were examined using sera from 70 paired umbilical cord and maternal blood samples.Results Serum CCL17 (r(s) = 0.340, P<0.001) and sHLA-G (r(s) = 0.600, P<0.001) levels showed high correlations between umbilical cord and maternal blood. Umbilical cord serum levels of CCL17 from neonates destined to develop AD in infancy were higher than in those from neonates who showed no signs of AD during infancy (median 1586.9 vs. 819.6 pg/mL, P<0.001). Serum levels of CCL17 were higher in mothers with AD than inthose without AD (median 909.6 vs. 214.1 pg/mL, P<0.001). High umbilical cord serum levels of CCL17 were associated with infantil |
DOI | 10.1111/j.1365-2222.2010.03634.x |
PMID | 21054588 |